About
Treatments from seaweed-derived polymers
Areas of Focus
Categories
Small Molecule PharmaceuticalAustria
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
1,083
By Phase
NA: 7PHASE2: 1PHASE3: 1
By Status
COMPLETED: 9
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06262100Lead Sponsor
Lubricating Effectiveness of Carragelose Eye Drops in Patients Affected by Mild to Moderate Dry Eye
NACompleted
30 participants
Started: Jan 15, 2024 · Completed: Jul 30, 2024
NCT04793984Lead Sponsor
Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients
NACompleted
14 participants
Started: Mar 8, 2021 · Completed: Jul 30, 2022
NCT04681001Lead Sponsor
Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers
NACompleted
300 participants
Started: Dec 20, 2020 · Completed: Aug 30, 2021
NCT04590365Collaborator
Carrageenan Nasal Spray for COVID-19 Prophylaxis
NACompleted
480 participants
Started: Dec 17, 2020 · Completed: Nov 18, 2022
NCT04531358Lead Sponsor
Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis
NACompleted
42 participants
Started: Aug 4, 2020 · Completed: Dec 31, 2020
Locations (1)
Headquarters
Korneuburg, Austria
Map
Loading map...